GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » Price-to-Operating-Cash-Flow

Sinopharm Tech Holdings (HKSE:08156) Price-to-Operating-Cash-Flow : (As of May. 27, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings Price-to-Operating-Cash-Flow?

As of today (2024-05-27), Sinopharm Tech Holdings's share price is HK$0.11. Sinopharm Tech Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.00. Hence, Sinopharm Tech Holdings's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Sinopharm Tech Holdings's Price-to-Operating-Cash-Flow or its related term are showing as below:

HKSE:08156' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0   Med: 0   Max: 54.28
Current: 4.23

During the past 13 years, Sinopharm Tech Holdings's highest Price-to-Operating-Cash-Flow Ratio was 54.28. The lowest was 0.00. And the median was 0.00.

HKSE:08156's Price-to-Operating-Cash-Flow is ranked better than
91.62% of 1801 companies
in the Software industry
Industry Median: 18.27 vs HKSE:08156: 4.23

Sinopharm Tech Holdings's Cash Flow from Operations per share for the three months ended in Dec. 2023 was HK$0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -43.60% per year.

During the past 13 years, Sinopharm Tech Holdings's highest 3-Year average Operating Cash Flow per Share Growth Rate was 73.70% per year. The lowest was -383.50% per year. And the median was 4.10% per year.


Sinopharm Tech Holdings Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Sinopharm Tech Holdings's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Tech Holdings Price-to-Operating-Cash-Flow Chart

Sinopharm Tech Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 33.10 - - 13.46

Sinopharm Tech Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 13.46 - -

Competitive Comparison of Sinopharm Tech Holdings's Price-to-Operating-Cash-Flow

For the Software - Application subindustry, Sinopharm Tech Holdings's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sinopharm Tech Holdings's Price-to-Operating-Cash-Flow Distribution in the Software Industry

For the Software industry and Technology sector, Sinopharm Tech Holdings's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Sinopharm Tech Holdings's Price-to-Operating-Cash-Flow falls into.



Sinopharm Tech Holdings Price-to-Operating-Cash-Flow Calculation

Sinopharm Tech Holdings's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.11/0
=

Sinopharm Tech Holdings's Share Price of today is HK$0.11.
Sinopharm Tech Holdings's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.00.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Sinopharm Tech Holdings Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Tech Holdings (HKSE:08156) Business Description

Traded in Other Exchanges
N/A
Address
Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18/F, Ruttonjee House, Hong Kong Central, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Lottery-related services; Provision of Internet Plus services (solution and supply chain), Manufacturing and distribution of personal protective equipment, and Others services. It generates maximum revenue from the internet plus services (solution and supply chain) segment. The Internet plus Supply chain services segment includes the provision of supply chain management, data analysis and related services, and trading of goods through the internet platform. Geographically, it derives a majority of revenue from Hong Kong.
Executives
Best Frontier Investments Limited
Chan Kin Ho Philip 2201 Interest of corporation controlled by you
Lam Yui Keung 2201 Interest of corporation controlled by you
Sinopharm Traditional Chinese Medicine Overseas Holdings Limited 2101 Beneficial owner
Main Key Investments Limited 2201 Interest of corporation controlled by you
Guo Lei 2201 Interest of corporation controlled by you
Integrated Asset Management (asia) Limited 2101 Beneficial owner
Yam Tak Cheung 2201 Interest of corporation controlled by you
Chan Tung Mei 2202 Interest of your spouse
Cheung Kwai Lan 2201 Interest of corporation controlled by you
Tse Siu Hoi 2101 Beneficial owner
Gam Star China Equity (a Sub-fund Of Gam Star Fund P.l.c.) 2102 Investment manager

Sinopharm Tech Holdings (HKSE:08156) Headlines

No Headlines